Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition
- PMID: 20655471
- PMCID: PMC2925155
- DOI: 10.1016/j.cell.2010.06.002
Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition
Erratum in
-
Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition.Cell. 2022 Feb 17;185(4):746. doi: 10.1016/j.cell.2022.01.016. Cell. 2022. PMID: 35180388 Free PMC article. No abstract available.
Abstract
Global energy balance in mammals is controlled by the actions of circulating hormones that coordinate fuel production and utilization in metabolically active tissues. Bone-derived osteocalcin, in its undercarboxylated, hormonal form, regulates fat deposition and is a potent insulin secretagogue. Here, we show that insulin receptor (IR) signaling in osteoblasts controls osteoblast development and osteocalcin expression by suppressing the Runx2 inhibitor Twist2. Mice lacking IR in osteoblasts have low circulating undercarboxylated osteocalcin and reduced bone acquisition due to decreased bone formation and deficient numbers of osteoblasts. With age, these mice develop marked peripheral adiposity and hyperglycemia accompanied by severe glucose intolerance and insulin resistance. The metabolic abnormalities in these mice are improved by infusion of undercarboxylated osteocalcin. These results indicate the existence of a bone-pancreas endocrine loop through which insulin signaling in the osteoblast ensures osteoblast differentiation and stimulates osteocalcin production, which in turn regulates insulin sensitivity and pancreatic insulin secretion.
Copyright 2010 Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2925155/bin/nihms213522f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2925155/bin/nihms213522f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2925155/bin/nihms213522f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2925155/bin/nihms213522f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2925155/bin/nihms213522f5.gif)
Comment in
-
No bones about it: insulin modulates skeletal remodeling.Cell. 2010 Jul 23;142(2):198-200. doi: 10.1016/j.cell.2010.07.001. Cell. 2010. PMID: 20655463
Similar articles
-
DLK1 Regulates Whole-Body Glucose Metabolism: A Negative Feedback Regulation of the Osteocalcin-Insulin Loop.Diabetes. 2015 Sep;64(9):3069-80. doi: 10.2337/db14-1642. Epub 2015 Apr 27. Diabetes. 2015. PMID: 25918236
-
Possible roles of insulin signaling in osteoblasts.Endocr Res. 2014;39(4):144-51. doi: 10.3109/07435800.2013.879168. Epub 2014 Mar 28. Endocr Res. 2014. PMID: 24679227 Review.
-
Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis.Mol Cell Biol. 2014 May;34(10):1850-62. doi: 10.1128/MCB.00075-14. Epub 2014 Mar 3. Mol Cell Biol. 2014. PMID: 24591652 Free PMC article.
-
Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism.J Bone Miner Res. 2011 Sep;26(9):2012-25. doi: 10.1002/jbmr.417. J Bone Miner Res. 2011. PMID: 21557308 Free PMC article.
-
Energy regulation by the skeleton.Nutr Rev. 2008 Apr;66(4):229-33. doi: 10.1111/j.1753-4887.2008.00027.x. Nutr Rev. 2008. PMID: 18366536 Review.
Cited by
-
Nutritional therapy bridges the critical cut-off point for the closed-loop role of type 2 diabetes and bone homeostasis: A narrative review.Heliyon. 2024 Mar 22;10(7):e28229. doi: 10.1016/j.heliyon.2024.e28229. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38689978 Free PMC article. Review.
-
El diálogo oculto entre el hueso y los tejidos a través del remodelado óseo.Adv Lab Med. 2023 Sep 22;5(1):35-45. doi: 10.1515/almed-2023-0101. eCollection 2024 Mar. Adv Lab Med. 2023. PMID: 38634083 Free PMC article. Spanish.
-
The hidden cross talk between bone and tissues through bone turnover.Adv Lab Med. 2023 Dec 12;5(1):24-34. doi: 10.1515/almed-2023-0160. eCollection 2024 Mar. Adv Lab Med. 2023. PMID: 38634076 Free PMC article.
-
Influence of Titanium Surface Residual Stresses on Osteoblastic Response and Bacteria Colonization.Materials (Basel). 2024 Apr 2;17(7):1626. doi: 10.3390/ma17071626. Materials (Basel). 2024. PMID: 38612139 Free PMC article.
-
Effect of Drugs Used in Pharmacotherapy of Type 2 Diabetes on Bone Density and Risk of Bone Fractures.Medicina (Kaunas). 2024 Feb 26;60(3):393. doi: 10.3390/medicina60030393. Medicina (Kaunas). 2024. PMID: 38541119 Free PMC article. Review.
References
-
- Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117:421–426. - PubMed
-
- Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell. 2004;6:423–435. - PubMed
-
- Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998;2:559–569. - PubMed
-
- Delmas PD, Wilson DM, Mann KG, Riggs BL. Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab. 1983;57:1028–1030. - PubMed
-
- Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197–207. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases